The Pennant Group (PNTG) Stock Forecast & Price Target

$31.07 -0.49 (-1.55%)

(As of 11:47 AM ET)

The Pennant Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 4 Analyst Ratings

Sell
0

Hold
1

Buy
3

Based on 4 Wall Street analysts who have issued ratings for The Pennant Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for PNTG.

Consensus Price Target

$38.25
23.11% Upside

According to the 4 analysts' twelve-month price targets for The Pennant Group, the average price target is $38.25. The highest price target for PNTG is $40.00, while the lowest price target for PNTG is $37.00. The average price target represents a forecasted upside of 23.11% from the current price of $31.07.

Get the Latest News and Ratings for PNTG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for The Pennant Group and its competitors.

PNTG Analyst Ratings Over Time

Type	Current Forecast 12/4/23 to 12/3/24	1 Month Ago 11/4/23 to 11/3/24	3 Months Ago 9/5/23 to 9/4/24	1 Year Ago 12/4/22 to 12/4/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	1 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$38.25	$37.50	$31.50	$14.50
Forecasted Upside	23.11% Upside	15.42% Upside	-3.99% Downside	5.84% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

This Crisis Could Be Worse Than 2008 (Ad)

Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America is teetering on the edge of a collapse unlike anything we've seen.

In my new book, "Midnight in America," I expose the hidden deals between Washington and Wall Street.

PNTG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PNTG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

The Pennant Group Stock vs. The Competition

Type	The Pennant Group	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	21.20% Upside	25,883.65% Upside	6.71% Upside
News Sentiment Rating	Positive News See Recent PNTG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
11/8/2024	Oppenheimer 3 of 5 stars	Boost Target	Outperform ➝ Outperform	$34.00 ➝ $37.00	+12.53%
10/23/2024	Royal Bank of Canada 4 of 5 stars	Boost Target	Outperform ➝ Outperform	$26.00 ➝ $38.00	+13.33%
10/9/2024	Stephens 4 of 5 stars	Reiterated Rating	Overweight ➝ Overweight	$40.00 ➝ $40.00	+20.12%
10/7/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold ➝ Hold	$34.00 ➝ $38.00	+15.15%
5/9/2023	VNET Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Maintains
2/27/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$15.00 ➝ $16.00	+15.52%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:26 PM ET.

PNTG Forecast - Frequently Asked Questions

: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for The Pennant Group is $38.25, with a high forecast of $40.00 and a low forecast of $37.00.
: 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Pennant Group in the last year. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PNTG shares.
: According to analysts, The Pennant Group's stock has a predicted upside of 23.11% based on their 12-month stock forecasts.
: The Pennant Group has been rated by research analysts at Oppenheimer, Royal Bank of Canada, Stephens, and Truist Financial in the past 90 days.
: Analysts like The Pennant Group less than other "medical" companies. The consensus rating score for The Pennant Group is 2.75 while the average consensus rating score for "medical" companies is 2.81. Learn more on how PNTG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

"Start Earning Extra Income with Just $30" (Ad)

What if you could unlock a steady income stream from stocks priced under $30? Our new guide walks you through simple, effective options strategies designed for everyday investors. With step-by-step insights, you’ll learn how to transform familiar names like Ford and Intel into reliable monthly income generators.

Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income”

This page (NASDAQ:PNTG) was last updated on 12/3/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Pennant Group (PNTG) Stock Forecast & Price Target